Agencies Jointly Issue RFI for Input on Regulating Biotechnology

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Agencies Jointly Issue RFI for Input on Regulating Biotechnology

Virtual Listening Session Scheduled for Jan. 12; Comments Due Feb. 3

Darla M. Fera

December 22, 2022 at 09:19 AM EST

Stakeholders now have an opportunity to provide input on the “regulatory ambiguities, gaps, inefficiencies or uncertainties” in the Coordinated Framework for the Regulation of Biotechnology, in response to a request for information (RFI) jointly issued by four federal agencies on Dec. 20 (87 Fed. Reg. 77900). The information provided will help the agencies — the White House O... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Agencies Jointly Issue RFI for Input on Regulating Biotechnology

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT